Indivior Pharmaceuticals INDV
NASDAQ INDV
$36.22 -0.37 (-1.01%)
As of: Sep 30, 2026 · 1:31 PM EDT

Indivior Pharmaceuticals, Inc. (INDV) EBT Margin (2024 - 2026)

Updated

Indivior Pharmaceuticals' EBT Margin was 46.65% in Q2 2026, up 26.12 percentage points from 20.53% a year earlier and up 10.37 percentage points from the prior quarter.

Analysis

Indivior Pharmaceuticals, Inc. (INDV) EBT Margin (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Indivior Pharmaceuticals' EBT Margin was 29.50% through Jun 30, 2026, up 13.41 percentage points year-over-year; for FY2025, it was 19.29%, up 17.61 percentage points from FY2024.

  • EBT Margin shows a four-year change of -4.73 percentage points (FY2021 to FY2025).
  • In earlier years, EBT Margin was 1.68% in FY2024 (+14.95 pp), -13.27% in FY2023 (-3.72 pp), -9.54% in FY2022 (-33.57 pp) and 24.02% in FY2021.
  • The Q2 2026 figure marks the highest quarterly EBT Margin in data going back to Q1 2024.
  • Compared with a year earlier, EBT Margin has increased for five straight quarters, with an average year-over-year change of +18.27 percentage points over the last six quarters.
  • Per Business Quant data, INDV's EBT Margin in the three quarters before Q2 2026 was 36.28% (Q1 2026), 22.63% (Q4 2025) and 11.78% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.65%
Mar 31, 2026 36.28%
Dec 31, 2025 22.63%
Sep 30, 2025 11.78%
Jun 30, 2025 20.53%
Mar 31, 2025 22.18%
Dec 31, 2024 12.71%
Sep 30, 2024 9.77%
Jun 30, 2024 -40.47%
Mar 31, 2024 25.70%
API Access

Indivior Pharmaceuticals, Inc. EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=INDV&period=max&api_key=YOUR_API_KEY